US Stock MarketDetailed Quotes

ENTA Enanta Pharmaceuticals

Watchlist
  • 6.030
  • -0.260-4.13%
Close Dec 13 16:00 ET
  • 6.060
  • +0.030+0.50%
Post 19:23 ET
127.80MMarket Cap-1.10P/E (TTM)

Enanta Pharmaceuticals Key Stats

Enanta Pharmaceuticals Q4 2024 Earnings Date

Currency:USDNov 25, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
17.83M
14.61M
-3.22M
Miss Est.
-5.83%
-22.84%
-18.07%
EPS
-1.07
-1.36
-0.29
Miss Est.
+19.33%
-2.26%
-26.77%
Buy

Dec 11, 2024

Enanta Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 16.422M--
--2025/Q1-- / 17.666M--
Nov 25, 20242024/Q414.607M / 17.828M--
Aug 5, 20242024/Q317.971M / 17.156M--
May 6, 20242024/Q217.054M / 16.207M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 16.422M--
--2025/Q1-- / 17.666M--
Nov 25, 20242024/Q414.607M / 17.828M--
Aug 5, 20242024/Q317.971M / 17.156M--
May 6, 20242024/Q217.054M / 16.207M--

Unlock Free Earnings Estimates

Enanta Pharmaceuticals Earnings Reports

Read more

Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Dec 11, 2024

Buy

  • Buy

    57.14%
  • Hold

    28.57%
  • Sell

    14.29%

Price Target

No Data